Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 6:37am EST - Canadian Markets open in 2 hours and 53 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
DexCom, Inc. (DXCM)
On Feb 9:
8.83 USD
0.00 (0.00%)
MORE ON DXCM
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
DexCom, Inc.
(NGM:DXCM) Delayed quote data
Last Trade:
8.83 USD
Trade Time:
Feb 9
Change:
0.00 (0.00%)
Prev Close:
8.83
Open:
N/A
Bid:
8.08
x 200
Ask:
8.95
x 400
1y Target Est:
9.83
Day's Range:
N/A - N/A
52wk Range:
3.18 - 10.20
Volume:
0
Avg Vol
(3m)
:
343,757
Market Cap:
406.45M
P/E
(ttm)
:
N/A
EPS
(ttm)
:
-1.58
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
Add DXCM to Portfolio
Download Data
HEADLINES
Test of "artificial pancreas" offers diabetes hope
at Reuters
(Thu, Feb 4)
5 Stocks Hitting New Highs Daily
at Investopedia
(Mon, Jan 25)
TCW Fund Seeks Small-Cap Winners
Investor's Business Daily
(Thu, Jan 21)
DexCom Reports Product Revenues
Zacks.com
(Mon, Jan 18)
DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exh
EDGAR Online
(Fri, Jan 15)
Dexcom upgraded by Soleil
Briefing.com
(Fri, Jan 15)
DexCom Announces the Sale of 3.5 Million Shares of Common Stock
Business Wire
(Thu, Jan 14)
DEXCOM INC Files SEC form 8-K, Change in Directors or Principal Officers, Other Events
EDGAR Online
(Thu, Jan 14)
J&J, charity to start testing artificial pancreas
AP
(Wed, Jan 13)
CORRECTED - UPDATE - Nonprofit, company team up for 'artificial pancreas'
at Reuters
(Wed, Jan 13)
DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online
(Tue, Jan 12)
More Headlines for DXCM...
ANALYST
EPS Est (next year)
(Dec-07)
:
-1.60
EPS Est (in 2 years)
(Dec-08)
:
-1.52
Avg Rec (current)*:
2.7
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
DexCom, Inc., a medical device company, engages in the design, development, and commercialization of continuous glucose monitoring systems for people with diabetes in the United States.
Full Company Profile
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices